Western Blotting Market is expected to reach US$ 992.55 Mn by 2027 with Thermo Fisher Scientific Inc., Merck KGaA, GENERAL ELECTRIC, Cell Signaling Technology, Inc., PerkinElmer, Inc. and others

According to The Insight Partners market research study titled ‘Western Blotting Market to 2027 – Global Analysis and Forecasts by Product, Application, End User and Geography. The Global Western Blotting Market is expected to reach US$ 992.55 Mn in 2027 from US$ 638.82 Mn in 2018. The market is estimated to grow with a CAGR of 5.2% from 2019-2027. The report highlights the trends prevalent in the global western blotting market and the factors driving the market along with those that act as challenges to its growth.

The major players operating in the western blotting market include, Thermo Fisher Scientific Inc., Merck KGaA, GENERAL ELECTRIC, Cell Signaling Technology, Inc., PerkinElmer, Inc., Bio-Rad Laboratories, Inc., LI-COR, Inc., OriGene Technologies, Inc., Rockland Immunochemicals Inc., and Abcam plc among the others. The companies are involved in various growth strategies that are enabling the growth of the market as well as for the company. For instance, in June, 2019, Thermo Fisher Scientific Inc. launched iBright 1500 Imaging System Series that includes two models, the Invitrogen iBright FL1500 imaging system and the Invitrogen iBright CL1500 imaging system for life science researchers.

Download Sample PDF Western Blotting Report Copy at: https://www.theinsightpartners.com/sample/TIPHE100001121/?openpr-10225

Market Insights

Rising Prevalence of Lyme and HIV

Western blot delivers both confirmatory results in the field of research and diagnostic testing. Lyme is the tick-borne disease in the region of North America. According to study published in 2018, by Carnegie Mellon University sates that Lyme disease is expected to rise in United States. Reason for rise in Lyme disease is the climate change. Various studies have shown western blot IgM has 94-96% of specificity towards the patient with clinical symptom of Lyme disease. Western blot is used in the confirmatory test for HIV followed by ELISA test. Western blot was specifically gold standard for the diagnosis of HIV-1 infection. According to data published on the site of HIV.gov in 2016, approximately 38,700 people were newly infected by HIV. Therefore, owing to the above mentioned factors it is expected that the market is likely to grow during the forecast period.

Automation in Western Blot Technique

Western blot is the major analytical tool to assess the molecular function in basic cell biology research, drug discovery and pathology. There have been significant improvement in the technical aspect of western blot which has led to improvement in efficiency, reproducibility, ease of use. For example, iBind Western Systems launched by ThermoFisher Scientific Corporation which is and automated western blot device which does not require continuous monitoring. Further the turnaround time is reduced compared to traditional method where it involves the various steps and four hours for final results. In iBind all the solution is required to be loaded rest all process is automated by sequential lateral flow technology (SLF) which does not require any electricity or batteries. The significant advantage provided by automated western blot system will contribute in the growth of the western blot market.

Application Insights

The global western blotting market by application segments was led by biomedical & biochemical research segment. In 2018, the biomedical & biochemical research held a largest market share of 38.58% of the western blotting market, by application. However, the others segment is expected to grow at the fastest growth rate during the forecast period, 2019 to 2027.

Strategic Insights

Organic and inorganic growth strategies were observed among which organic strategy was the most adopted strategy in global western blotting industry. For instance, in June, 2019. Thermo Fisher Scientific Inc. launched iBright 1500 Imaging System Series that includes two models, the Invitrogen iBright FL1500 imaging system and the Invitrogen iBright CL1500 imaging system for life science researchers. Thus, various product launch in the market are likely to influence the market growth during forecast period.

Western Blotting – MARKET SEGMENTATION

By Product

Instruments
Imagers
Gel Electrophoresis Instruments
Blotting Systems
Consumables
Kits
Reagents
Others

By Application

Biomedical & Biochemical Research
Agricultures
Others

By End User

Biotechnological & Pharmaceutical Companies
Diagnostic Laboratories
Academic & Research Institutes
Others

By Geography

North America
U.S.
Canada
Mexico
Europe
France
Germany
UK
Spain
Italy
Asia Pacific (APAC)
China
India
Japan
Australia
South Korea
Middle East & Africa (MEA)
Saudi Arabia
South Africa
UAE
South America (SAM)
Brazil
Argentina

Buy Complete Western Blotting Report at: https://www.theinsightpartners.com/buy/TIPHE100001121/?openpr-10225

Contact Us

Contact Person: Sameer Joshi

Phone: +1-646-491-9876

Email Id: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.